Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study (Evidence for Cardiovascular Outcomes With Sodium Glucose Cotransporter 2 Inhibitors in the Real World).

Author: Udell, Jacob A. MD, MPH; Yuan, Zhong MD, PhD; Rush, Toni MPH; Sicignano, Nicholas M. MPH; Galitz, Michael MD; Rosenthal, Norman MD

Page: 1450-1459

https://ift.tt/2JdCcVb